News on Access Pharmaceuticals from BioPortfolio.com http://www.BioPortfolio.com Consolidated Access Pharmaceuticals news from BioPortfolio.com Wed, 10 Feb 2010 15:47:48 GMT en GlaxoSmithKline Introduces CARES by GSK to Improve Patient Access to GSK Oncology and Specialty Medicineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042536&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042536&THISHREF=http://c.moreover.com/click/here.pl%3fz2539448479%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042536&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042536&THISHREF=http://c.moreover.com/click/here.pl%3fz2539448479%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Rexahn Pharmaceuticals (Amex: RNN): An Undiscovered Biotech With ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043186&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043186&THISHREF=http://c.moreover.com/click/here.pl%3fz2539643638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043186&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043186&THISHREF=http://c.moreover.com/click/here.pl%3fz2539643638%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Research and Markets: Company Financials: Optimer Pharmaceuticals, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043152&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043152&THISHREF=http://c.moreover.com/click/here.pl%3fz2539627879%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043152&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043152&THISHREF=http://c.moreover.com/click/here.pl%3fz2539627879%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Research and Markets: Company Financials: Jazz Pharmaceuticals, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043151&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043151&THISHREF=http://c.moreover.com/click/here.pl%3fz2539627540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043151&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043151&THISHREF=http://c.moreover.com/click/here.pl%3fz2539627540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Research and Markets: Company Financials: Isis Pharmaceuticals, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043150&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043150&THISHREF=http://c.moreover.com/click/here.pl%3fz2539627341%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043150&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043150&THISHREF=http://c.moreover.com/click/here.pl%3fz2539627341%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Research and Markets: Company Financials: ISTA Pharmaceuticals, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043146&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043146&THISHREF=http://c.moreover.com/click/here.pl%3fz2539625997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043146&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043146&THISHREF=http://c.moreover.com/click/here.pl%3fz2539625997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Rexahn Pharmaceuticals (Amex: RNN): An Undiscovered Biotech With Multiple Catalysts Poised to See Significanthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043118&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043118&THISHREF=http://c.moreover.com/click/here.pl%3fz2539617009%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043118&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043118&THISHREF=http://c.moreover.com/click/here.pl%3fz2539617009%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Rexahn Pharmaceuticals (Amex: RNN): An Undiscovered Biotech With Multiple Catalysts Poised to See Significant Price Moves in the Short Termhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042998&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042998&THISHREF=http://c.moreover.com/click/here.pl%3fz2539573482%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042998&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042998&THISHREF=http://c.moreover.com/click/here.pl%3fz2539573482%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Rexahn Pharmaceuticals (Amex: RNN): An Undiscovered Biotech With Multiple Catalysts Poised to See Significant Price Moves in the Short Termhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042977&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042977&THISHREF=http://c.moreover.com/click/here.pl%3fz2539569187%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042977&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042977&THISHREF=http://c.moreover.com/click/here.pl%3fz2539569187%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Rexahn Pharmaceuticals (Amex: RNN): An Undiscovered Biotech With Multiple Catalysts Poised to See Significant Price Moves in thhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042948&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042948&THISHREF=http://c.moreover.com/click/here.pl%3fz2539558970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042948&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042948&THISHREF=http://c.moreover.com/click/here.pl%3fz2539558970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Rexahn Pharmaceuticals (Amex: RNN): An Undiscovered Biotech With Multiple Catalysts Poised to See Significanthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042941&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042941&THISHREF=http://c.moreover.com/click/here.pl%3fz2539556324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042941&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042941&THISHREF=http://c.moreover.com/click/here.pl%3fz2539556324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Access Pharmaceuticals, Inc. Restructures to Fhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036038&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036038&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476483%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036038&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036038&THISHREF=http://c.moreover.com/click/here.pl%3fz2536476483%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCitybizlist: Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 16, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037494&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037494&THISHREF=http://c.moreover.com/click/here.pl%3fz2537111103%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037494&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037494&THISHREF=http://c.moreover.com/click/here.pl%3fz2537111103%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via Yahoo!: Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 16, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037482&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037482&THISHREF=http://c.moreover.com/click/here.pl%3fz2537100716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037482&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037482&THISHREF=http://c.moreover.com/click/here.pl%3fz2537100716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 16, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037336&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037336&THISHREF=http://c.moreover.com/click/here.pl%3fz2537034428%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037336&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Access%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037336&THISHREF=http://c.moreover.com/click/here.pl%3fz2537034428%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: